These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25828130)

  • 21. Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials.
    Nairooz R; Saad M; Dhillon AS; Yousaf H; Awar L; Mehra A; Matthews RV; Shavelle D; Clavijo L
    Cardiovasc Revasc Med; 2018 Dec; 19(8):951-955. PubMed ID: 30078629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
    Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of characteristics and outcomes of patients undergoing saphenous vein graft stenting who were or were not enrolled in the stenting of saphenous vein grafts randomized controlled trial.
    Michael TT; Badhey N; Banerjee S; Brilakis ES
    J Investig Med; 2011 Feb; 59(2):259-66. PubMed ID: 21200334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting versus bare-metal stents for treating saphenous vein grafts.
    Shishehbor MH; Hawi R; Singh IM; Tuzcu EM; Bhatt DL; Ellis SG; Kapadia SR
    Am Heart J; 2009 Oct; 158(4):637-43. PubMed ID: 19781425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts.
    Iqbal J; Kwok CS; Kontopantelis E; de Belder MA; Ludman PF; Large A; Butler R; Gamal A; Kinnaird T; Zaman A; Mamas MA;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study.
    Hoffmann R; Pohl T; Köster R; Blindt R; Boeckstegers P; Heitzer T
    Heart; 2007 Mar; 93(3):331-4. PubMed ID: 16940392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New-generation drug eluting stent vs. bare metal stent in saphenous vein graft - 1 year outcomes by a propensity score ascertainment (SVG Baltic Registry).
    Wańha W; Mielczarek M; Roleder T; Ładziński S; Milewski M; Gilis-Malinowska N; Chmielecki M; Ciećwierz D; Bachorski W; Kunik P; Trznadel A; Męcka K; Genc A; Januszek R; Pączek P; Dziewierz A; Bartuś S; Gruchała M; Smolka G; Dudek D; Navarese EP; Ochała A; Jaguszewski M; Wojakowski W
    Int J Cardiol; 2019 Oct; 292():56-61. PubMed ID: 31003797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
    Rodés-Cabau J; Bertrand OF; Larose E; Déry JP; Rinfret S; Bagur R; Proulx G; Nguyen CM; Côté M; Landcop MC; Boudreault JR; Rouleau J; Roy L; Gleeton O; Barbeau G; Noël B; Courtis J; Dagenais GR; Després JP; DeLarochellière R
    Circulation; 2009 Nov; 120(20):1978-86. PubMed ID: 19884468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduits.
    Kitabata H; Loh JP; Pendyala LK; Badr S; Dvir D; Barbash IM; Minha S; Torguson R; Chen F; Satler LF; Suddath WO; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2013 Jul; 112(1):61-7. PubMed ID: 23561590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.
    Lee MS; Yang T; Kandzari DE; Tobis JM; Liao H; Mahmud E
    Am J Cardiol; 2010 Apr; 105(8):1076-82. PubMed ID: 20381656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.
    Maes F; Jolly SS; Cairns J; Delarochellière R; Côté M; Dzavik V; Rodés-Cabau J
    J Invasive Cardiol; 2019 Nov; 31(11):E308-E315. PubMed ID: 31671060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.
    Okabe T; Lindsay J; Buch AN; Steinberg DH; Roy P; Slottow TL; Smith K; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
    Am J Cardiol; 2008 Sep; 102(5):530-4. PubMed ID: 18721507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
    Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
    Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-eluting versus bare-metal stents for saphenous vein graft lesions.
    Conte SM; Florisson DS; De Bono JA; Vale PR
    Intern Med J; 2019 Dec; 49(12):1534-1537. PubMed ID: 31808253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study.
    Ko DT; Guo H; Wijeysundera HC; Zia MI; Džavík V; Chu MW; Fremes SE; Cohen EA; Tu JV
    JACC Cardiovasc Interv; 2011 Sep; 4(9):965-73. PubMed ID: 21939936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
    Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
    J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis.
    Applegate RJ; Sacrinty M; Kutcher M; Santos R; Gandhi S; Little W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):7-12. PubMed ID: 18412239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.